Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study
BackgroundPatient- and caregiver-reported data are lacking on the burden of spasticity, and the impact of botulinum neurotoxin type A (BoNT-A) treatment for this condition, on patients' daily lives. As recommended in recent guidance from the US Food and Drug Administrati...
Main Authors: | Patel, Atul T, Wein, Theodore, Bahroo, Laxman B, Wilczynski, Ophélie, Rios, Carl D, Murie-Fernández, Manuel |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2020-12-01
|
Series: | JMIR Public Health and Surveillance |
Online Access: | http://publichealth.jmir.org/2020/4/e17928/ |
Similar Items
-
Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
by: Jorge Jacinto, et al.
Published: (2020-05-01) -
Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
by: Jorge Jacinto, et al.
Published: (2020-12-01) -
Ergonomic Recommendations in Ultrasound-Guided Botulinum Neurotoxin Chemodenervation for Spasticity: An International Expert Group Opinion
by: Philippe Lagnau, et al.
Published: (2021-03-01) -
Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
by: Bernard Poulain, et al.
Published: (2019-01-01) -
Botulinum Neurotoxin-A Injection in Adult Cervical Dystonia and Spastic Paresis: Results From the INPUT (INjection Practice, Usage and Training) Survey
by: Tae Mo Chung, et al.
Published: (2020-09-01)